Efficiency of Cytokine-Induced Killer Cells in Combination with Chemotherapy for Triple-Negative Breast Cancer

PURPOSE: The treatment of triple-negative breast cancer (TNBC) remains challenging, due to the absence of estrogen, progesterone, and human epidermal growth factor receptors. This study was designed to evaluate the efficiency and safety of cytokine-induced killer (CIK) cell immunotherapy, following...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Breast Cancer
Autori principali: Li, Man, Wang, Yang, Wei, Feng, An, Xiumei, Zhang, Naining, Cao, Shui, Ren, Baozhu, Zhang, Xinwei, Ren, Xiubao
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Breast Cancer Society 2018
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6015982/
https://ncbi.nlm.nih.gov/pubmed/29963110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2018.21.2.150
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi